Literature DB >> 15988784

Prenatal diagnosis of echogenic lung: evolution and outcome.

S Illanes1, A Hunter, M Evans, E Cusick, P Soothill.   

Abstract

OBJECTIVES: Despite the feasibility of detecting lung lesions by antenatal ultrasound, there are problems in correlating the prenatal diagnosis with the final histology and in predicting the outcome. In order to better describe these factors, we reviewed the outcome of fetuses that had been diagnosed with echogenic lung in a referral fetal medicine unit.
METHODS: We searched the database of a tertiary fetal medicine unit for all cases of fetal echogenic lung seen since 1994 and studied the maternal and neonatal records found.
RESULTS: There were 48 cases of echogenic lung diagnosed at a median gestational age of 21 (range, 19-29) weeks, including 43 (90%) cases of congenital cystic adenomatoid malformation (CCAM) and 5 (10%) of pulmonary sequestration (PS). The evolution of the fetal abnormality after diagnosis was: in 22 (45.8%) cases the lesion disappeared; in 17 (35.5%) cases the lesion remained stable and six (12.5%) cases became severe. Three (6%) women underwent termination of pregnancy. The lesions were equally distributed between the two sides of the thorax. Mediastinal shift was associated with a threefold increase in the possibility of clinical deterioration (17% vs. 5%), and the disappearance of the lesion was twice as likely to occur when the lesion was classified as microcystic as when it was macrocystic (67% vs. 36%). Features of hydrops were found in 9 (21%) fetuses and in six (13%) cases progressed and resulted in intrauterine or neonatal death. Sixty-four percent of cases with lesions that disappeared during the pregnancy had an abnormal computed tomography (CT) scan, and the prenatal diagnosis correlated with histology in 36% of these cases. Of the cases in which the lesions remained stable, 70.5% had an abnormal CT scan and the prenatal diagnosis correlated with the histology in 67% of the cases.
CONCLUSIONS: Prenatally diagnosed echogenic lung has a good prognosis in the absence of hydrops. The ability to correctly assess echogenic lung lesions and the need for surgery by prenatal ultrasound is limited. Copyright 2005 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15988784     DOI: 10.1002/uog.1921

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  8 in total

1.  Imaging of fetal chest masses.

Authors:  Richard A Barth
Journal:  Pediatr Radiol       Date:  2012-03-06

Review 2.  [Fetal magnetic resonance imaging. Diagnostics in cases of congenital cystadenomatoid malformation of the lung (CCAM)].

Authors:  K A Büsing; A K Kilian; T Schaible; K W Neff
Journal:  Radiologe       Date:  2006-02       Impact factor: 0.635

3.  Congenital lung lesions: classification and concordance of radiological appearance and surgical pathology.

Authors:  M K Farrugia; S A Raza; S Gould; K Lakhoo
Journal:  Pediatr Surg Int       Date:  2008-07-30       Impact factor: 1.827

4.  Intralobar sequestration associated with cystic adenomatoid malformation: diagnostic and thoracoscopic pitfalls.

Authors:  Smart Zeidan; Geraldine Hery; Ferderic Lacroix; Guillaume Gorincour; Alain Potier; Jean Christophe Dubus; Jean-Michel Guys; Pascal de Lagausie
Journal:  Surg Endosc       Date:  2008-10-15       Impact factor: 4.584

5.  Antenatally diagnosed congenital cystic adenomatoid malformations (CCAM): Research Review.

Authors:  Fosca Antonia Francesca Di Prima; Adriano Bellia; Genny Inclimona; Francesco Grasso; Maria Teresa; Meli Nazario Cassaro
Journal:  J Prenat Med       Date:  2012-04

6.  Comparison between US and MRI in the prenatal assessment of lung malformations.

Authors:  Nicole Beydon; Michèle Larroquet; Aurore Coulomb; Jean-Marie Jouannic; Hubert Ducou le Pointe; Annick Clément; Catherine Garel
Journal:  Pediatr Radiol       Date:  2013-01-30

7.  Genetic anomalies in fetuses with tetralogy of Fallot by using high-definition chromosomal microarray analysis.

Authors:  Ruan Peng; Ju Zheng; Hong-Ning Xie; Miao He; Mei-Fang Lin
Journal:  Cardiovasc Ultrasound       Date:  2019-05-06       Impact factor: 2.062

8.  Management Options for Fetal Bronchopulmonary Sequestration.

Authors:  Magdalena Litwinska; Ewelina Litwinska; Krzysztof Szaflik; Marzena Debska; Tomasz Szajner; Katarzyna Janiak; Piotr Kaczmarek; Miroslaw Wielgos
Journal:  J Clin Med       Date:  2022-03-20       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.